2+ -free solution. LL-37 (4 and 8 μ M ) reduced the MG63 cell number both in the presence and absence of Ca 2+ in the medium. In conclusion, LL-37 reduces the osteoblast cell number by promoting apoptosis, and furthermore, LL-37 stimulates Ca 2+ inflow via a mechanism independent of voltagesensitive Ca 2+ channels. Interestingly, LL-37-induced lowering of the cell number seems to be mediated via a mechanism independent of Ca 2+ .
tralizing lipopolysaccharides [4] [5] [6] . The cationic LL-37 molecule binds to negatively charged microbial membrane lipids thereby showing membrane selectivity [3] . Furthermore, LL-37 potentiates chemokine production by microbial stimuli in keratinocytes and other epithelial cells, suggesting that it enhances the immune defense of the skin [7] .
LL-37 has, besides its antimicrobial and immune modulator activities, also been shown to affect various cellular functions, such as phagocytosis [8] , cell differentiation [9] and apoptosis [10] [11] [12] [13] [14] [15] [16] . Importantly, the effects of LL-37 on apoptosis seem to be cell type specific; LL-37 promotes apoptosis in vascular smooth muscle cells [10] , periodontal ligament cells [11] , neutrophils [12] , T cells [13] and airway epithelium [14] but suppresses apoptosis in keratinocytes [15] and dermal fibroblasts [16] . For neutrophils, LL-37 has been reported to exert both proand antiapoptotic effects [12, 17] .
In periodontitis, which is a progressive inflammatory disease, the end stage is characterized by destruction of the alveolar bone leading to loss of teeth. Interestingly, the LL-37 concentrations are high (μ M ) in the gingival crevicular fluid from patients suffering from chronic periodontitis [18] , suggesting that this peptide may influence the disease process. The bone-forming osteoblasts represent a very important cell type in both periodontal health and disease responsible for maintaining the alveolar bone mass [19] .
The signaling pathways and mechanisms involved in LL-37-regulated apoptosis are not completely understood [3] . The Ca 2+ ion is thought to play a role in cell killing and apoptosis, and dysfunctional regulation of Ca 2+ homeostasis can result in apoptosis [20, 21] , suggesting that Ca 2+ may be involved in LL-37-induced proapoptotic signaling. LL-37 has been reported to interact with different cellular proteins such as the purinergic P2X 7 receptor [17, 22] and the epidermal growth factor receptor [23] [24] [25] , but LL-37 interacts also with DNA [26] . In the present study, we investigate effects of LL-37 on human osteoblast-like MG63 cell viability and Ca 2+ signaling demonstrating that LL-37 induces apoptosis also in this cell type. Additionally, we demonstrate that LL-37 causes a rapid and sustained rise in the intracellular Ca 2+ concentration through inflow of Ca 2+ from the extracellular space, suggesting that LL-37 alters Ca 2+ handling. Interestingly, the LL-37-induced reduction of the osteoblast cell number and cell viability seems to be mediated through a mechanism independent of Ca 2+ .
Materials and Methods

Cell Culture and Experimental Procedure
The human osteoblast-like MG63 cell line and the primary human osteoblast cell line hFOB 1.19 from the American Type Tissue Culture Collection (ATCC, Manassas, Va., USA) were cultured in DMEM/Ham's F12 (1: 1) cell culture medium (Life Technologies, Invitrogen, Carlsbad, Calif., USA) supplemented with antibiotics (penicillin 50 U/ml, streptomycin 50 μg/ml) and 10% fetal calf serum in accordance with instructions from ATCC. The cells were kept in a water-jacketed cell incubator at 37 ° C under 5% CO 2 in air. The MG63 cells express markers for osteogenic differentiation such as alkaline phosphatase enzyme activity and form mineralized nodules showing that they are representative for native osteoblasts [27, 28] . The cells were trypsinized (0.25% trypsin/EDTA) and reseeded upon reaching confluence. Medium was exchanged every second day. Experiments were performed on subconfluent cells (80% confluence). The cells were used for experiments in passages 3-10. Incubation with LL-37 caused similar effects irrespective of passage number. Before experiments fetal calf serum was omitted in order to standardize the experimental conditions. For experiments assessing the importance of Ca 2+ for LL-37-induced effects on cell number, MG63 cells were incubated in either DMEM cell culture medium containing 1.8 m M Ca 2+ or Ca 2+ -free DMEM medium, both from Life Technologies. The Ca 2+ -free DMEM medium was further supplemented with 1.8 m M MgCl 2 to achieve isoosmolar conditions and to supplement with divalent cations to compensate for those lost by the omission of Ca 2+ . In order to achieve culture conditions with low Ca 2+ concentration, the Ca 2+ -containing DMEM medium was supplemented with 1.8 m M of the Ca 2+ chelator ethylene glycol-bis(β-aminoethyl ether)-N,N,N ′ ,N ′ -tetraacetic acid (EGTA, Sigma Chemicals, St. Louis, Mo., USA).
Assessment of Cell Number and Cell Viability
The number of cells was calculated in a Bürker chamber as appropriate. Cell viability was assessed using trypan blue exclusion test. The cells were incubated for 2 min with 0.4% trypan blue (Sigma) and then washed 3 times in 0.9% NaCl. Cells containing trypan blue were counted as a measure of dead/dying cells. Cell morphology was assessed in digital photographs from a Nikon TMS microscope equipped with a digital camera (Pixelink, Nikon, Nikon Nordic AB, Solna, Sweden).
Determination of Active Caspase 3
After washing in phosphate-buffered saline (PBS), cellular proteins were extracted using a protein extraction buffer provided in the active caspase 3 ELISA kit from R&D (R&D Systems, Minneapolis, Minn., USA). The amount of active caspase 3 was determined by ELISA according to the manufacturer's instructions and normalized to total protein in each sample measured by a Bio-Rad protein assay kit (BioRad, Hercules, Calif., USA). Each sample was analyzed in duplicate.
Annexin V Flow Cytometry
Apoptosis was assessed by flow cytometry using Annexin V staining. Cells were washed with PBS and then incubated with FITC-labeled Annexin V and the fluorescent viability dye 7-aminoactinomycin D (7-AAD) using the FITC Annexin V apoptosis detection kit 1 (BD, Franklin Lakes, N.J., USA) according to the manufacturer's instructions. The proportion of Annexin V-positive/negative and 7-AAD-positive/negative cells was determined by flow cytometry using an Accuri C6 flow cytometer (BD). Cells in early stages of apoptosis are Annexin V positive and 7-AAD negative, whereas cells in later stages of apoptosis and necrosis stain positive for both Annexin V and 7-AAD. Gates for Annexin V-and 7-AAD-positive cells were set using fluorescence minus one control. 20,000 events were recorded in each sample. . This Ca 2+ concentration is somewhat higher than the plasma concentration of Ca 2+ in healthy adults. We used HEPES-buffered salt solution with 2.5 m M Ca 2+ only in these acute experiments. The composition of the HEPES-buffered salt solution was (m M ): NaCl 135.5, KCl 5.9, CaCl 2 2.5, MgCl 2 1.2, HEPES 11.6 and glucose 11.5. In some experiments measurement of Ca 2+ was performed under Ca 2+ -free conditions, i.e. in HEPES-buffered salt solution without CaCl 2 and with the addition of 2 m M EGTA (Sigma). The experiments were performed at room temperature. Fluorescence was recorded using a laser-scanning confocal microscope (LSM 510 PASCAL, Carl Zeiss AG, Göttingen, Germany). The excitation and emission wavelengths were 488 and 505 nm, respectively. The Ca 2+ measurements were performed on subconfluent (80% confluence) cells as an integrated signal from all cells (about 300 cells) within the visual field at ×100 magnification. The confocal pinhole setting was kept identical for all experiments.
Measurement of Intracellular Ca
Drugs LL-37 was purchased from Bachem AG (Bubendorf, Switzerland) and dissolved in dimethyl sulfoxide (DMSO) according to the manufacturer's instructions. The L-type Ca 2+ channel blocker nifedipine (Sigma), the thromboxane A 2 analogue U46619 (Tocris Bioscience, Bristol, UK) and the P2X 7 receptor antagonist AZ11645373 (Tocris) were dissolved in DMSO. The controls received vehicle, DMSO, as appropriate. The final concentration of DMSO was 0.1%.
Statistics
Values are presented as means ± SEM. Statistical significance was calculated using ANOVA and Student's two-tailed t test for unpaired comparisons with Bonferroni correction for post hoc analysis as appropriate. p values <0.05 were regarded to denote statistical significance.
Results
LL-37 Reduces MG63 Cell Number and Cell Viability
Treatment with LL-37 for 24 h reduced the number of human MG63 osteoblasts by 40 and 75% at 4 and 8 μ M , respectively ( fig. 1 a) . Lower concentrations of LL-37 (0.1-2 μ M ) had no effect on the number of cells ( fig. 1 a) . LL-37 caused a concentration-dependent decrease in the 
LL-37 Increases the Number of Annexin V-Positive Cells and Elevates Active Caspase 3 in MG63 Cells
Treatment with LL-37 (4 μ M ) for 6 h increased the proportion of Annexin V-positive MG63 cells by about 70% as demonstrated by flow cytometry ( fig. 4 a) . The wellknown proapoptotic agent staurosporine (0.5 μ M ) was included as a positive control [29] . Treatment with 0.5 μ M staurosporine for 6 h increased the number of Annexin V-positive cells by about 9 times ( fig. 4 a) . Staurosporine (0.5 μ M ) but not LL-37 (4 μ M ) increased the proportion of Annexin V-positive cells also at a shorter time point, i.e. 2 h ( fig. 4 a) . Stimulation with LL-37 (4 μ M ) for 24 h increased the amount of active caspase 3 between 2 and 3 times in MG63 cells ( fig. 4 b) . The positive control staurosporine (0.5 μ M ) increased active caspase 3 by about 2-fold ( fig. 4 b) . Taken together these data show that LL-37 is proapoptotic for osteoblasts.
LL-37 Increases MG63 Intracellular Ca
2+
Concentration
Defective cellular Ca 2+ handling is thought to be involved in proapoptotic signaling [21] , and therefore we assessed the effects of LL-37 on the intracellular Ca fig. 5 a, b) . A lower concentration of LL-37 (0.4 μ M ) also elevated Ca 2+ , but the Ca 2+ response to 0.4 μ M LL-37 was small compared to that of 4 μ M ( fig. 5 b) . The addition of vehicle control (0.1% DMSO) had no effect on Ca 2+ ( fig. 5 a) . LL-37 (0.4 and 4 μ M ) had no effect on intracellular Ca 2+ concentration in Ca 2+ -free solution ( fig. 5 c) , suggesting that the LL-37-induced increase in Ca 2+ depends on inflow of extracellular Ca 2+ . Treatment with 100 n M and 1 μ M of the L-type voltage-sensitive Ca 2+ channel blocker nifedipine had no effect on the LL-37-induced Ca 2+ response (4 μ M LL-37), suggesting that LL-37 acts via another mechanism than by stimulation of Ca 2+ inflow through L-type Ca 2+ channels ( fig. 6 , 7 a) . The T-type Ca 2+ channel blocker NiCl 2 (100 μ M ) had no effect on the LL-37-induced (4 μ M ) Ca 2+ response ( fig. 7 b) , suggesting that inflow of Ca 2+ by LL-37 is mediated through another pathway than via T-type Ca 2+ channels. Furthermore, inclusion of the P2X 7 receptor antagonist AZ11645373 (10 μ M ) had no impact on the rise in Ca 2+ evoked by 4 μ M LL-37 ( fig. 7 c) . The thromboxane A 2 analogue U46619 was included as positive control causing a rapid and powerful rise in intracellular Ca 2+ concentration ( fig. 7 d) . 
LL-37 Reduces MG63 Cell Number Both in the Presence and Absence of Extracellular Ca
2+
Treatment with LL-37 (8 μ M ) for 24 h reduced the number of MG63 cells by about 55% for cells cultured in DMEM culture medium containing 1.8 m M Ca 2+ and by about 85% for cells cultured in Ca 2+ -free DMEM culture medium ( fig. 8 a) . In fact, the LL-37-induced reduction of the cell number was more powerful (p < 0.01) in the absence than in the presence of extracellular Ca 2+ ( fig. 8 a) . A lower concentration of LL-37 (4 μ M ) reduced the cell number by about 15% in the presence (86 ± 2% for LL-37-treated cells vs. 100 ± 5% for control cells, p < 0.05, n = 3 in each group) and by about 35% in the absence (66 ± 7% for LL-37-treated cells vs. 100 ± 16% for control cells, p < 0.05, n = 3 in each group) of extracellular Ca 2+ . Omitting Ca 2+ for 24 h reduced slightly, but not significantly, the number of cells as demonstrated when cell counts are plotted as absolute data ( fig. 8 b) . The MG63 cells showed a similar morphology in the presence and absence of Ca 2+ ( fig. 8 c) . Treatment with LL-37 (4 μ M ) for 24 h reduced the cell number by about 60% when the Ca containing DMEM culture medium in order to lower Ca 2+ ( fig. 9 ). LL-37 (4 μ M ) also reduced the cell number by about 60% when extra Ca 2+ (final Ca 2+ concentration 3.6 m M ) was included in the EGTA-containing medium ( fig. 9 ). For these experiments EGTA was administered in an equimolar concentration to extracellular Ca 2+ (1.8 m M ) in order to bind most of the Ca 2+ ions. Thus, LL-37-induced lowering of the osteoblast cell number is observed both when the cells are cultured under Ca 2+ -free conditions and when Ca 2+ ions are absorbed with EGTA.
Discussion
In the present study, we demonstrate that the human antimicrobial peptide LL-37 induces apoptosis in human osteoblast-like MG63 cells and that this effect is associated with an elevated intracellular Ca 2+ concentration. LL-37 causes, in the micromolar concentration range, an acute and sustained rise in intracellular Ca 2+ in Ca 2+ -containing but not in Ca 2+ -free solution showing that the LL-37-induced increase in intracellular Ca 2+ is due to an inflow of Ca 2+ along its gradient from the extracellular space to the cytosol. The increase in Ca 2+ by LL-37 was much stronger at 4 than at 0.4 μ M , suggesting a concen- tration-dependent effect, although it is difficult to come to firm conclusions about the concentration dependence since we have investigated only two concentrations of LL-37. Membrane depolarization results in an inflow of Ca 2+ from the extracellular space, causing a sustained and long-lasting increase in intracellular Ca 2+ [30] similar to that observed in response to LL-37 in the present study. The pattern of LL-37-induced rise in intracellular Ca 2+ concentration is thus compatible with inflow of Ca 2+ from the extracellular space. Osteoblasts (MC3T3-E1 cells and MG63 cells) have been reported to express voltage-sensitive Ca 2+ channels [31, 32] . Our data show that neither the L-type Ca 2+ channel blocker nifedipine nor the T-type Ca 2+ channel blocker NiCl 2 have an impact on the LL-37-evoked rise in Ca 2+ in MG63 cells, suggesting that the inflow of Ca 2+ triggered by LL-37 is through another mechanism than via voltage-sensitive L-type and T-type Ca 2+ channels. We used relevant concentrations of nifedipine (0.1 and 1 μ M ), which fully inhibit the inflow of Ca 2+ via L-type Ca 2+ channels in cultured vascular smooth muscle cells [30] , and NiCl 2 (100 μ M ) inhibiting T-type but not L-type Ca 2+ channels [33] . Furthermore, inclusion of the selective and highly potent P2X 7 receptor antagonist AZ11645373 [34] had no effect on the rise in Ca 2+ evoked by LL-37, suggesting an alternative mechanism. Based on our findings presented here, we suggest that the LL-37-induced inflow of extracellular Ca 2+ represents a novel signaling pathway for LL-37 that may involve LL-37-induced permeabilization of the cell membrane causing formation of transmembrane pores and/or that LL-37 acts as a detergent. These data implicate that LL-37 may work through a similar mechanism in human osteoblasts as in LL-37-induced permeabilization of the bacterial cell wall [3] .
Here, we show for the first time that the antimicrobial peptide LL-37 reduces the human MG63 osteoblast cell number by promoting apoptosis. LL-37-induced apoptosis was demonstrated by both an enhanced proportion of Annexin V-positive cells and by an elevated active caspase 3 level in response to LL-37 treatment. Furthermore, LL-37-treated cells showed altered morphology such as cell shrinkage representing a classical sign of apoptosis. Previously, proapoptotic effects of LL-37 have been demonstrated in vascular smooth muscle cells, periodontal ligament cells, neutrophils, T cells and airway epithelial cells [10] [11] [12] [13] [14] . We demonstrate a reduction of the osteoblast cell number by LL-37 in the micromolar concentration range, while no effect on the cell number is observed at lower concentrations of LL-37. We have previously shown that LL-37 reduces lipopolysaccharide-induced MCP-1 and IL-6 expression at low concentrations (0.1 and 1 μ M ) and induces apoptosis only at high (>5 μ M ) concentrations in human periodontal ligament cells [11] . LL-37-induced proapoptosis is thus observed in different cell systems but only in the micromolar concentration range. Very high levels of LL-37 have been demonstrated in lesional tissue from patients suffering from autoimmune diseases such as psoriasis, rosacea and ulcerative colitis [35] [36] [37] . For example, the median concentration of LL-37 is 304 μ M in psoriatic skin lesions [35] . The LL-37 levels are elevated locally in chronic periodontitis; in fact, they are well within the micromolar concentration range [18] , suggesting that LL-37-induced apoptosis of osteoblasts may have an impact on alveolar bone homeostasis in patients suffering from this disease. Thus, we may conclude that the LL-37-induced apoptosis of osteoblasts, observed in the micromolar concentration range in the present study, is relevant for the in vivo situation considering the very high levels of LL-37 observed in various autoimmune and inflammatory diseases. Ca 2+ governs many important cellular processes and is thought to be involved in apoptosis [21, 38] . A rise in intracellular Ca 2+ may originate from intracellular stores such as the endoplasmic reticulum but also from the extracellular space [21] . Here, we show that LL-37 elevates intracellular Ca 2+ concentration in human MG63 osteoblasts through stimulation of Ca 2+ inflow. The LL-37-evoked inflow of Ca 2+ seems not to be critically important for the LL-37-induced reduction of the MG63 cell number, since LL-37 lowers the cell number both in the presence and absence of Ca 2+ in the cell culture medium and, furthermore, LL-37 causes a rise in intracellular Ca 2+ but no apoptosis at a low concentration (0.4 μ M ). Ca 2+ -independent apoptosis has been described in different experimental systems [39, 40] . Interestingly, the LL-37-evoked inward flow of Ca 2+ , occurring independently of LL-37-induced apoptosis, may represent an important mechanism regulating Ca 2+ -dependent cellular processes governed by LL-37. Thus, we demonstrate here that LL-37 alters human osteoblast Ca 2+ handling and induces Ca 2+ -independent apoptosis.
In summary, we show that LL-37 alters cellular Ca through a voltage-sensitive L-and T-type Ca 2+ channelindependent mechanism in human osteoblasts. Furthermore, we demonstrate that LL-37 induces apoptosis of osteoblasts via a mechanism that is independent of Ca 2+ .
